Literature DB >> 3346698

Peripheral neuropathy associated with erythrophagocytic lymphohistiocytosis.

B Boutin1, M C Routon, F Rocchiccioli, M Mayer, G Leverger, O Robain, G Ponsot, M Arthuis.   

Abstract

A 12 year old patient who developed clinical, biochemical and histological features of erythrophagocytic lymphohistiocytosis is described. In contrast to previously reported cases, the prominent neurological feature was a subacute sensorimotor polyneuropathy. Sural nerve biopsy showed a marked reduction of myelinated fibres and severe axonal lesions, absence of histiocyte infiltration and deposits of IgM along the epineurium. In addition to the hypertriglyceridaemia previously described in this condition, an elevation of plasma very long-chain fatty acids and phytanic acid was found which suggests a transient impairment of peroxisomal functions.

Entities:  

Mesh:

Year:  1988        PMID: 3346698      PMCID: PMC1031548          DOI: 10.1136/jnnp.51.2.291

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  Generalized lymphohistiocytic infiltration. A familial disease not previously described and different from Letterer-Siwe disease and Chediak-Higashi syndrome.

Authors:  P NELSON; A SANTAMARIA; R L OLSON; N C NAYAK
Journal:  Pediatrics       Date:  1961-06       Impact factor: 7.124

2.  [Familial lymphohistocytosis].

Authors:  P Mozziconacci; C Nezelof; C Attal; F Girard
Journal:  Arch Fr Pediatr       Date:  1965-04

3.  Fatal Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  E R Wilson; A Malluh; S Stagno; W M Crist
Journal:  J Pediatr       Date:  1981-02       Impact factor: 4.406

4.  Familial erythrophagocytic lymphohistiocytosis: an association with serum lipid abnormalities.

Authors:  L E Ansbacher; B H Singsen; M W Hosler; H Grimminger; P N Herbert
Journal:  J Pediatr       Date:  1983-02       Impact factor: 4.406

Review 5.  Familial erythrophagocytic lymphohistocytosis. Report of two cases and clinicopathologic review.

Authors:  M C Perry; E G Harrison; E O Burgert; G S Gilchrist
Journal:  Cancer       Date:  1976-07       Impact factor: 6.860

6.  Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.

Authors:  R J Risdall; R W McKenna; M E Nesbit; W Krivit; H H Balfour; R L Simmons; R D Brunning
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

7.  Familial erythrophagocytic lymphohistiocytosis. A neuropathologic study.

Authors:  J J Martin; P Cras
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation.

Authors:  A Fischer; J L Virelizier; F Arenzana-Seisdedos; N Perez; C Nezelof; C Griscelli
Journal:  Pediatrics       Date:  1985-08       Impact factor: 7.124

9.  Impaired natural killer activity in lymphohistiocytosis syndrome.

Authors:  N Perez; J L Virelizier; F Arenzana-Seisdedos; A Fischer; C Griscelli
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

10.  Capillary gas-liquid chromatographic-mass spectrometric measurement of very long chain (C22 to C26) fatty acids in microliter samples of plasma.

Authors:  P Aubourg; P F Bougnères; F Rocchiccioli
Journal:  J Lipid Res       Date:  1985-02       Impact factor: 5.922

  10 in total
  1 in total

Review 1.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.